Results 171 to 180 of about 3,568,234 (327)

Efficacy of Rituximab as Adjunctive Therapy to Immunosuppressive Agents in Adult Primary Focal Segmental Glomerulosclerosis. [PDF]

Kidney Int Rep
Mohamed ON, Mohamed MI, Mohammed Elsaghir SM, Abdelrazek S, Azzam A, Senosy Mohamed TM, Mohammed HMH, Yousef R, Abd Rabou AA, Abdelazeem Elgarhy RY, Mohamed Mahdy AK, Abdelsamie MA, Sayed MM, Fathi E, Mohammed Toni ND, Saleh RK, Fathy B.   +16 more
europepmc   +1 more source

Immunosuppressive Agents

, 2016
Karen L. Hardinger, Irfan A. Agha, Daniel C. Brennan   +2 more
openaire   +1 more source

QuantiFERON test interpretation in patients receiving immunosuppressive agents: an alert

European Respiratory Journal, 2017
J. Belliere, A. Blancher
semanticscholar   +1 more source

Treating vasculitis with conventional immunosuppressive agents [PDF]

, 2012
David Jayne
openalex   +1 more source

TriCON: A Carbon‐Based Triple‐Modal Nanoplatform for Pancreatic Cancer Therapy

Advanced Science, EarlyView.
We developed TriCON, a triple‐modality nanotherapeutic platform, to treat pancreatic ductal adenocarcinoma (PDAC) by synergizing gene editing, chemotherapy, and immunotherapy. TriCON utilizes CRISPR/Cas9 to target the poliovirus receptor (PVR), combined with nano‐encapsulated doxorubicin and checkpoint blockade. This approach achieved significant tumor
Xinyu Peng, Jiaxing Huang, Shengnan Lv, Jian Zhang, Liangliang Zhang, Huan Liu, Yan Liu, Zhen‐An Qiao, Feng Wei, Bao‐Lian Su   +9 more
wiley   +1 more source

[Immunosuppressive agents].

ADM; revista de la Asociacion Dental Mexicana, 1969
O, Hrodek, J, Melková
  +8 more sources

Complications Associated with Immunosuppressive Agents in Solid Organ Transplant Recipients: A Nationwide Analysis. [PDF]

J Clin Med
Lee AY, Jeong J, Heo KN, Park S, Ah YM, Han JM, Lee JY, Min SI.   +7 more
europepmc   +1 more source

Cleavage‐Resistant CYLD Protects Against Autoimmune Hepatitis

Advanced Science, EarlyView.
Proteolytic cleavage of the deubiquitinase CYLD emerges as a critical driver of autoimmune hepatitis. TNFα‐induced CYLD loss in macrophages amplifies S100A9‐triggered MAPK activation, leading to excessive chemokine production and hepatic inflammation. Pharmacological inhibition of MEK signaling effectively attenuates experimental disease, highlighting ...
Han Liu, Chen Su, Jianling Liu, Mingyan Xing, Xiaoxia Wu, Lingxia Wang, Xiaoming Zhao, Hanwen Zhang, YangYang Xie, YangYang Wang, Hong Li, Yu Li, Ming Li, Haibing Zhang   +13 more
wiley   +1 more source

Enterocolic Lymphocytic Phlebitis Treated Preoperatively with Biologics and Immunosuppressive Agents. [PDF]

Case Rep Pathol, 2022
Okano S, Yao T, Nomura O, Nagahara A, Hagiwara T, Sugimoto K, Takahashi M, Sakamoto K.   +7 more
europepmc   +1 more source

Immunosuppressive Agents in Multiple Sclerosis [PDF]

, 2007
Oliver Neuhaus, Bernd C. Kieseier, Hans‐Peter Hartung   +2 more
openalex   +1 more source